815 participants
Sargramostim, Vaccine Therapy, or Sargramostim and Vaccine Therapy in Preventing Disease Recurrence in Patients With Melanoma That Has Been Removed By Surgery
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-06-24
- Start Date:
- 2000-02-23
- Completion:
- 2012-10-08
Conditions
- Iris Melanoma
- Medium/Large Size Posterior Uveal Melanoma
- Mucosal Melanoma
- Ocular Melanoma With Extraocular Extension
- Recurrent Melanoma
- Recurrent Uveal Melanoma
- Small Size Posterior Uveal Melanoma
- Stage IIA Cutaneous Melanoma AJCC v6 and v7
- Stage IIA Uveal Melanoma AJCC v7
- Stage IIB Cutaneous Melanoma AJCC v6 and v7
- Stage IIB Uveal Melanoma AJCC v7
- Stage IIC Cutaneous Melanoma AJCC v6 and v7
- Stage IIIA Cutaneous Melanoma AJCC v7
- Stage IIIA Uveal Melanoma AJCC v7
- Stage IIIB Cutaneous Melanoma AJCC v7
- Stage IIIB Uveal Melanoma AJCC v7
- Stage IIIC Cutaneous Melanoma AJCC v7
- Stage IIIC Uveal Melanoma AJCC v7
- Stage IV Cutaneous Melanoma AJCC v6 and v7
- Stage IV Uveal Melanoma AJCC v7
Interventions
- OTHER
- BIOLOGICAL